Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2025-10-20 00:00:00 ET · period of report 2025-10-17 · accession 0001610717-25-000368 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-10-20 | 2025-10-17 | RVMD | Cislini Jeff | GC | M - OptEx | $36.57 | +12.0K | 62.4K | +24% | +$438.8K |
| DT | 2025-10-20 | 2025-10-17 | RVMD | Cislini Jeff | GC | S - Sale+OE | $55.00 | -12.0K | 50.4K | -19% | -$660.0K |
| DT | 2025-10-20 | 2025-10-17 | RVMD | Cislini Jeff | GC | M - OptEx | $0.00 | -12.0K | 18.0K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-17 | M | A | 12,000 | $36.57 | 62,425 | D | — | — | (F2) Includes 43,910 restricted stock units. |
| 2 | Common | Common Stock | 2025-10-17 | S | D | 12,000 | $55.00 | 50,425 | D | — | — | (F2) Includes 43,910 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-10-17 | M | D | 12,000 | $0.00 | 18,000 | D | $36.57 · 2024-06-15 to 2030-06-16 | 12,000 Common Stock |